ALEMS Stock Overview
Engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
European Medical Solutions Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.02 |
| 52 Week High | €0.037 |
| 52 Week Low | €0.002 |
| Beta | 0.50 |
| 11 Month Change | -1.00% |
| 3 Month Change | 1.54% |
| 1 Year Change | 23.75% |
| 33 Year Change | -93.44% |
| 5 Year Change | -98.23% |
| Change since IPO | -99.71% |
Recent News & Updates
Would DMS Imaging (EBR:ALIMG) Be Better Off With Less Debt?
Jun 15
DMS Imaging SA (EBR:ALIMG) Soars 29% But It's A Story Of Risk Vs Reward
Dec 21DMS Imaging SA's (EBR:DMSIM) Subdued P/S Might Signal An Opportunity
Jun 15Recent updates
Shareholder Returns
| ALEMS | BE Biotechs | BE Market | |
|---|---|---|---|
| 7D | -13.2% | 8.7% | 0.6% |
| 1Y | 23.8% | -0.5% | 4.8% |
Return vs Industry: ALEMS exceeded the Belgian Biotechs industry which returned -0.5% over the past year.
Return vs Market: ALEMS exceeded the Belgian Market which returned 4.8% over the past year.
Price Volatility
| ALEMS volatility | |
|---|---|
| ALEMS Average Weekly Movement | 16.1% |
| Biotechs Industry Average Movement | 7.2% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in BE Market | 6.7% |
| 10% least volatile stocks in BE Market | 2.5% |
Stable Share Price: ALEMS has not had significant price volatility in the past 3 months.
Volatility Over Time: ALEMS's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Belgian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 122 | Frank Hazevoets | www.dms-imaging.com |
European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. It offers R/F solutions, including PLATINUM NEO, a smart solution that revolutionizes the R/F workflow, as well as OPTIMA dRF, a robust solution; bone densitometry and body composition analysis equipment; chest and bone rooms, such as floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; and mammography solutions. The company was formerly known as DMS Imaging SA and changed its name to European Medical Solutions in June 2024.
European Medical Solutions Fundamentals Summary
| ALEMS fundamental statistics | |
|---|---|
| Market cap | €29.49m |
| Earnings (TTM) | -€709.00k |
| Revenue (TTM) | €42.53m |
0.7x
P/S Ratio-41.6x
P/E RatioIs ALEMS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALEMS income statement (TTM) | |
|---|---|
| Revenue | €42.53m |
| Cost of Revenue | €27.44m |
| Gross Profit | €15.09m |
| Other Expenses | €15.80m |
| Earnings | -€709.00k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.00048 |
| Gross Margin | 35.48% |
| Net Profit Margin | -1.67% |
| Debt/Equity Ratio | 143.2% |
How did ALEMS perform over the long term?
See historical performance and comparison